Serological follow-up in patients with aorto-iliac disease and evidence of Q fever infection

  • J. C. J. P. HagenaarsEmail author
  • N. H. M. Renders
  • A. S. van Petersen
  • S. O. A. Shamelian
  • M. G. L. de Jager-Leclercq
  • F. L. Moll
  • P. C. Wever
  • O. H. J. Koning


The aim of this study was to provide data on the risk of developing chronic Q fever in patients with aorto-iliac disease and evidence of previous Q fever infection. Patients with an aortic and/or iliac aneurysm or aorto-iliac reconstruction (aorto-iliac disease) and evidence of previous Q fever infection were included. The presence of phase I and II Coxiella burnetii IgG antibodies was assessed periodically using immunofluorescence assay. A total of 111 patients with aorto-iliac disease were divided into three groups, based upon the serological profile [mean follow-up: 16 ± 9 months (mean ± standard deviation)]. Group 1 consisted of 30 patients with a serological trace of C. burnetii infection (negative IgG phase I, IgG phase II titer of 1:32). Of these, 36.7 % converted to serological profile matching past resolved Q fever. Group 2 included 49 patients with negative IgG phase I titer and IgG phase II titer ≥1:64. No patients developed chronic Q fever, but 14.3 % converted to a positive IgG phase I titer. Group 3 consisted of 32 patients with positive IgG phase I and positive IgG phase II titers, of which 9.4 % developed chronic Q fever (significantly different from group 2, p = 0.039). The IgG phase I titer increased in 28.1 % of patients (from 1:64 to 1:4,096). The risk of developing chronic Q fever in patients with aorto-iliac disease and previous Q fever infection with a positive IgG phase I titer was 9.4 %. The IgG phase I titer increases or becomes positive in a substantial number of patients. A standardized serological follow-up is proposed.


Initial Infection Coxiella Burnetii Fever Patient Serological Profile Iliac Aneurysm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This study was financially supported by the Netherlands Organisation for Health Research and Development (ZonMw, grant no. 205520001). The sponsor had no involvement in the study design, data collection, data analysis, or interpretation of the study results. The authors declare no conflict of interest.

We would like to thank Bart Verhoeven, Ruud van Loenhout, and Ronald van den Haak, vascular surgeons, Jeroen Bosch Hospital, ’s-Hertogenbosch, and dr. T. Smits, dr. H. de Geus, and dr. M. Booster, vascular surgeons, Bernhoven Hospital, Uden, for their participation in recruiting patients for screening. We would like to thank Olivier Dams for approving the manuscript grammatically.

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    Maurin M, Raoult D (1999) Q fever. Clin Microbiol Rev 12(4):518–553PubMedCentralPubMedGoogle Scholar
  2. 2.
    Parker NR, Barralet JH, Bell AM (2006) Q fever. Lancet 367(9511):679–688PubMedCrossRefGoogle Scholar
  3. 3.
    Raoult D, Marrie T, Mege J (2005) Natural history and pathophysiology of Q fever. Lancet Infect Dis 5(4):219–226PubMedCrossRefGoogle Scholar
  4. 4.
    Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E et al (2000) Q fever 1985–1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 79(2):109–123CrossRefGoogle Scholar
  5. 5.
    Hagenaars JCJP, Kampschreur LM, de Jager-Leclercq MGL, van Petersen AS, Moll FL, Renders NHM et al (2014) Two cases with acute abdominal aneurysm and evidence of acute Q fever infection. Ann Vasc Surg 28(2):494Google Scholar
  6. 6.
    Hogema BM, Slot E, Molier M, Schneeberger PM, Hermans MH, van Hannen EJ et al (2012) Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in the Netherlands. Transfusion 52(1):144–150PubMedCrossRefGoogle Scholar
  7. 7.
    Schimmer B, Morroy G, Dijkstra F, Schneeberger PM, Weers-Pothoff G, Timen A et al (2008) Large ongoing Q fever outbreak in the south of The Netherlands, 2008. Euro Surveill 13(31):18939PubMedGoogle Scholar
  8. 8.
    Healy B, Llewelyn M, Westmoreland D, Lloyd G, Brown N (2006) The value of follow-up after acute Q fever infection. J Infect 52:e109–e112PubMedCrossRefGoogle Scholar
  9. 9.
    Kampschreur LM, Dekker S, Hagenaars JCJP, Lestrade PJ, Renders NHM, de Jager-Leclercq MGL et al (2012) Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis 18(4):563–570PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D (2001) Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 33(3):312–316PubMedCrossRefGoogle Scholar
  11. 11.
    Brouqui P, Dupont HT, Drancourt M, Berland Y, Etienne J, Leport C et al (1993) Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med 153(5):642–648PubMedCrossRefGoogle Scholar
  12. 12.
    Tissot-Dupont H, Vaillant V, Rey S, Raoult D (2007) Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 44(2):232–237PubMedCrossRefGoogle Scholar
  13. 13.
    Kampschreur LM, Oosterheert JJ, Koop AM, Wegdam-Blans MCA, Delsing CE, Bleeker-Rovers CP et al (2012) Microbiological challenges in the diagnosis of chronic Q fever. Clin Vaccine Immunol 19(5):787–790PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Teunis PFM, Schimmer B, Notermans DW, Leenders ACAP, Wever PC, Kretzschmar MEE et al (2013) Time-course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiol Infect 141(1):62–73PubMedCrossRefGoogle Scholar
  15. 15.
    Wielders CCH, Morroy G, Wever PC, Coutinho RA, Schneeberger PM, van der Hoek W (2013) Strategies for early detection of chronic Q-fever: a systematic review. Eur J Clin Invest 43(6):616–639PubMedCrossRefGoogle Scholar
  16. 16.
    van der Hoek W, Versteeg B, Meekelenkamp JC, Renders NH, Leenders AC, Weers-Pothoff I et al (2011) Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis 52(12):1431–1436PubMedCrossRefGoogle Scholar
  17. 17.
    Landais C, Fenollar F, Thuny F, Raoult D (2007) From acute Q fever to endocarditis: serological follow-up strategy. Clin Infect Dis 44(10):1337–1340PubMedCrossRefGoogle Scholar
  18. 18.
    Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF (2008) Q fever: Epidemiology, diagnosis, and treatment. Mayo Clin Proc 83(5):574–579PubMedCrossRefGoogle Scholar
  19. 19.
    Wagner-Wiening C, Brockmann S, Kimmig P (2006) Serological diagnosis and follow-up of asymptomatic and acute Q fever infections. Int J Med Microbiol 296(Suppl 40):294–296PubMedCrossRefGoogle Scholar
  20. 20.
    Anderson A, Bijlmer H, Fournier PE, Graves S, Hartzell J, Kersh GJ et al (2013) Diagnosis and management of Q fever—United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 62(RR-03):1–30PubMedGoogle Scholar
  21. 21.
    Kampschreur LM, Oosterheert JJ, Hoepelman AI, Lestrade PJ, Renders NH, Elsman P et al (2012) Prevalence of chronic Q fever in patients with a history of cardiac valve surgery in an area where Coxiella burnetii is epidemic. Clin Vaccine Immunol 19(8):1165–1169PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Botelho-Nevers E, Fournier PE, Richet H, Fenollar F, Lepidi H, Foucault C et al (2007) Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome. Eur J Clin Microbiol Infect Dis 26(9):635–640PubMedCrossRefGoogle Scholar
  23. 23.
    Wegdam-Blans MCA, Wielders CCH, Meekelenkamp J, Korbeeck JM, Herremans T, Tjhie HT et al (2012) Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera. Clin Vaccine Immunol 19(7):1110–1115PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Schneeberger PM, Hermans MH, van Hannen EJ, Schellekens JJ, Leenders AC, Wever PC (2010) Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol 17(2):286–290PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • J. C. J. P. Hagenaars
    • 1
    Email author
  • N. H. M. Renders
    • 2
  • A. S. van Petersen
    • 3
  • S. O. A. Shamelian
    • 4
  • M. G. L. de Jager-Leclercq
    • 5
  • F. L. Moll
    • 6
  • P. C. Wever
    • 2
  • O. H. J. Koning
    • 1
  1. 1.Department of SurgeryJeroen Bosch Hospital’s-HertogenboschThe Netherlands
  2. 2.Department of Medical Microbiology and Infection ControlJeroen Bosch Hospital’s-HertogenboschThe Netherlands
  3. 3.Department of SurgeryBernhoven HospitalUdenThe Netherlands
  4. 4.Department of Internal MedicineJeroen Bosch Hospital’s-HertogenboschThe Netherlands
  5. 5.Department of Internal MedicineBernhoven HospitalUdenThe Netherlands
  6. 6.Department of SurgeryUniversity Medical Centre UtrechtUtrechtThe Netherlands

Personalised recommendations